4

4D Molecular Therapeutics

Develops gene therapies using AAV vectors

TMF Quality Specialist

Clinical Research OperationsPosted on Nov 10
ContractEmeryville, CA, USA$52 - $61 /hrIn-person

About the Job

Requirements

  • Minimum 5 years of relevant experience in TMF Operations, including extensive hands-on work with Veeva Vault eTMF.
  • At least 2 years performing TMF quality control review, applying knowledge of clinical documentation content and metadata standards.
  • Experience supporting TMF planning, implementation, and configuration activities, including review of TMF Plans and participation in system setup or enhancements.
  • Demonstrated understanding of the CDISC Reference Model, TMF structure, ICH/GCP, Good Documentation Practice, and regulatory documentation requirements.
  • Experience partnering with or overseeing CROs performing TMF activities.
  • Hands-on involvement in system reporting, dashboard development, or configuration testing within Veeva Vault.
  • Exposure to multiple phases of clinical trial conduct, from startup through close-out and TMF archiving.
  • Proficiency in Microsoft Office Suite, especially Excel for tracking, sorting, filtering, and managing large metadata sets.
  • Interpersonal skills, including conflict resolution in a fast-paced, deadline-driven environment.
  • Strong attention to detail and organizational skills, including the ability and drive to follow through on detailed tasks to closure.
  • Analytical skills to evaluate and interpret complex situations or problems using multiple sources of information.

Responsibilities

  • Perform detailed quality control reviews of Trial Master File documents to verify metadata accuracy, confirm proper filing, and ensure compliance with ICH Good Clinical Practice, regulatory standards, and internal standard operating procedures.
  • Identify documentation gaps, inconsistencies, or quality issues and collaborate with TMF Operations team members to resolve them promptly.
  • Support ongoing TMF review activities throughout the study lifecycle to help ensure quality, timeliness, and completeness.
  • Assist with audit and inspection preparation by supporting the TMF team in documentation readiness activities.
  • Contribute to the continuous improvement of Oversight Review processes within Veeva Vault eTMF, including workflows, dashboards, and metrics.
  • Support development of review standards, success metrics, and monitoring tools that provide visibility into TMF quality, completeness, and inspection readiness.
  • Support TMF Operations leadership in identifying process improvement opportunities and contributing to new tools, workflows, and best practices.
  • Assist in preparing business requirements, documenting user needs, and participating in validation testing and user acceptance activities from the Business Process Owner perspective.
  • Provide input into change control documentation and support cross-functional collaboration with IT, Quality, and Managed Services teams during configuration updates.
  • Help develop training materials, reference guides, and user communications to support adoption of new functionality or process changes.

Desired Qualifications

  • Familiarity with additional Veeva products such as CTMS or Vault RIM.

About the Company

4D Molecular Therapeutics

Develops gene therapies using AAV vectors

4D Molecular Therapeutics develops gene therapies using its Therapeutic Vector Evolution platform to create adeno-associated virus (AAV) delivery vectors that transport therapeutic genes to patients’ cells. This clinical-stage biotech focuses on genetic diseases such as cystic fibrosis, delivering genetic material through engineered AAV vectors in targeted tissues. Its product approach involves R&D and clinical trials to test safety and efficacy, followed by commercialization through direct sales or partnerships with larger pharmaceutical companies. The company differentiates itself with a proprietary vector evolution technology that enables tailored, precise gene delivery and by pursuing funding and collaborations (e.g., with the Cystic Fibrosis Foundation) to advance therapies like 4D-710. The goal is to bring gene therapies to market to treat serious genetic diseases and improve patient outcomes, funded by equity investments, strategic partnerships, and future product sales.

Company size
201-500
Company stage
IPO
Headquarters
Emeryville, CA
Founded
2013

Recently Posted Jobs

Explore more opportunities at 4D Molecular Therapeutics

See more jobs